SCHEMBL989008

SCHEMBL989008

O=C1CCCN1CCCCCCCCCCCCN1CCCC1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 1/20 0.52
ADRA1B P35368 6/20 0.50
KMT2A Q03164 3/20 0.50
ADRA1A P35348 2/20 0.50
MEN1 O00255 1/20 0.50
PKM P14618 1/20 0.50
TSHR P16473 1/20 0.50
CYP1A2 P05177 1/20 0.47
CHRM2 P08172 1/20 0.47
CHRM4 P08173 1/20 0.47
CHRM5 P08912 1/20 0.47
CYP2D6 P10635 1/20 0.47
CHRM1 P11229 1/20 0.47
CYP2C9 P11712 1/20 0.47
CHRM3 P20309 1/20 0.47
CYP2C19 P33261 1/20 0.47
POLB P06746 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
BRD4 O60885 1/20 0.46
BRD2 P25440 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31632694 1.00 PIK3CD (0.52) PIK3CDADRA1BKMT2AADRA1AMEN1
SCHEMBL19514132 1.00 PIK3CD (0.52) PIK3CDADRA1BKMT2AADRA1AMEN1
SCHEMBL5697292 1.00 PIK3CD (0.52) PIK3CDADRA1BKMT2AADRA1AMEN1
SCHEMBL10481722 0.98 PIK3CD (0.50) PIK3CDADRA1BKMT2AADRA1AMEN1
SCHEMBL5424673 0.93 PIK3CD (0.54) PIK3CDADRA1BKMT2AADRA1AMEN1
SCHEMBL22799156 0.90 KMT2A (0.47) PIK3CDADRA1BKMT2AADRA1AMEN1
SCHEMBL22799085 0.90 KMT2A (0.47) PIK3CDADRA1BKMT2AADRA1AMEN1
SCHEMBL4398012 0.90 ADRA1B (0.44) PIK3CDADRA1BKMT2AADRA1AMEN1
SCHEMBL22042597 0.90 KMT2A (0.47) PIK3CDADRA1BKMT2AADRA1AMEN1
SCHEMBL22799028 0.90 KMT2A (0.47) PIK3CDADRA1BKMT2AADRA1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8012985-B2 parasiticides, in particularly against Plasmodium and babesia; antimalarial agents CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2011-09-06 US disclosed
EP-2275100-A2 Compounds with anti-parasitic activity and drugs containing said compounds Centre National de la Recherche Scientifique (CNRS) (FR) 2011-01-19 EP disclosed
EP-2266555-A2 Compounds with antiparasitic activity and medicines containing same Centre National de la Recherche Scientifique (CNRS) (FR) 2010-12-29 EP disclosed
EP-2260840-A2 Compounds with antiparasitic activity and medicines containing same Centre National de la Recherche Scientifique (CNRS) (FR) 2010-12-15 EP disclosed
EP-2260841-A2 Compounds with antiparasitic activity and medicines containing same Centre National de la Recherche Scientifique (CNRS) (FR) 2010-12-15 EP disclosed
US-20050176819-A1 Compounds with antiparasitic activity and medicines containing same CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N. (FR) 2005-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176819-A1 Compounds with antiparasitic activity and medicines containing same ACHE, MPO, PDF PIK3CD 2472/4885ADRA1B 2194/4885KMT2A 3373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.